Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
Imatinib and Trametinib for KRAS-mutated Solid Tumor
ClinicalTrials.gov study NCT06962254. IPD Sharing: YES. Countries: 1. Publications: 0.
Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia
ClinicalTrials.gov study NCT00244829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib TDM in GIST
ClinicalTrials.gov study NCT05493215. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP Patients
ClinicalTrials.gov study NCT04933526. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00053248. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg
ClinicalTrials.gov study NCT05623774. IPD Sharing: NO. Countries: 1. Publications: 0.
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
ClinicalTrials.gov study NCT06090669. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
ClinicalTrials.gov study NCT03516279. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
ClinicalTrials.gov study NCT00570635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study
ClinicalTrials.gov study NCT01025505. IPD Sharing: NO. Countries: 1. Publications: 0.
Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib
ClinicalTrials.gov study NCT02607332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate
ClinicalTrials.gov study NCT01426334. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00425646. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial
ClinicalTrials.gov study NCT04106024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma
ClinicalTrials.gov study NCT00402662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00041041. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
ClinicalTrials.gov study NCT00956072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL
ClinicalTrials.gov study NCT01148134. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans
ClinicalTrials.gov study NCT00084630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01126814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.